0001567619-22-011518.txt : 20220523 0001567619-22-011518.hdr.sgml : 20220523 20220523163119 ACCESSION NUMBER: 0001567619-22-011518 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220520 FILED AS OF DATE: 20220523 DATE AS OF CHANGE: 20220523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zhen Marianne CENTRAL INDEX KEY: 0001750085 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 22952146 MAIL ADDRESS: STREET 1: C/O INNOVIVA, INC. STREET 2: 2000 SIERRA POINT PARKWAY, SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc. CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 6502389600 MAIL ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: THERAVANCE INC DATE OF NAME CHANGE: 20020207 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 doc1.xml FORM 4 X0306 4 2022-05-20 0 0001080014 Innoviva, Inc. INVA 0001750085 Zhen Marianne 1350 OLD BAYSHORE HIGHWAY, SUITE 400 BURLINGAME CA 94040 0 1 0 0 Chief Accounting Officer Common Stock 2022-05-13 4 A 0 1834 0 A 40706 D Common Stock 2022-05-20 4 F 0 828 16.29 D 39878 D Includes 1,834 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on May 13, 2022. The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants. /s/ Marianne Zhen 2022-05-23